Wells Fargo & Company »

Viking Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.9M 60k 82.00
2023-12-31 $536k 29k 18.61
2023-09-30 $1.4M 126k 11.07
2023-06-30 $1.6M 100k 16.21
2022-12-31 $14k 1.5k 9.40
2022-09-30 $2.7k 1.2k 2.23
2022-06-30 $9.3k 3.2k 2.91
2022-03-31 $174k 58k 3.00
2021-12-31 $371k 81k 4.60
2021-09-30 $1.3M 114k 11.76
2021-06-30 $1.5M 127k 11.76
2021-03-31 $1.2M 192k 6.32
2020-12-31 $1.7M 297k 5.63
2020-09-30 $1.4M 246k 5.82
2020-06-30 $1.8M 256k 7.21
2020-03-31 $1.1M 227k 4.67
2019-12-31 $1.9M 235k 8.03
2019-09-30 $1.8M 255k 6.87
2019-06-30 $2.0M 246k 8.31
2019-03-31 $3.1M 313k 9.95
2018-12-31 $2.2M 292k 7.65
2018-09-30 $1.1M 66k 17.41
2018-06-30 $558k 59k 9.49
2016-09-30 $9.0k 6.3k 1.44
2016-06-30 $8.0k 6.3k 1.28
2016-03-31 $9.0k 6.3k 1.44
2015-12-31 $21k 6.3k 3.36